Print  Email
Abstract Categories by Council Award
AHA scientific councils sponsor numerous awards and travel grants for students, trainees and early career investigators whose abstracts are accepted for presentation at Scientific Sessions. Learn more about award criteria and application information.

Applicants for the following awards may only be considered for a council's award or travel grant if the abstract is submitted to an abstract category primarily sponsored by that council. Please select a council award below to view a list of eligible abstract categories for that particular award.
Early Career Investigator Awards
+Louis N. & Arnold M. Katz Basic Sci Research Prize for Young Investigators
  • 301 - Gene Expression/Molecular Biology (BCVS)
  • 302 - In-Vivo Gene Transfer: Experimental (BCVS)
  • 303 - Cardiac Development (BCVS)
  • 304 - Genetically Engineered Models of Human Disease (BCVS)
  • 401 - Ion Channels and membrane Transporters (BCVS)
  • 402 - Cellular Electrophysiology/Electropharmacology (BCVS)
  • 403 - Arrhythmias in Experimental Models (BCVS)
  • 404 - Cellular Aspects of Excitation-Contraction Coupling (BCVS)
  • 501 - Cardiac Failure and Remodeling (BCVS)
  • 510 - Molecular Basis of Hypertrophy (BCVS)
  • 511 - Cardiac Regeneration/Cellular Therapy - Experimental (BCVS)
  • 512 - Myocardial Structure and Pathology (BCVS)
  • 513 - Ventricular Function/Mechanics(BCVS)
  • 514 - Myocardial Energetics/Intermediary Metabolism (BCVS)
  • 515 - Protection of Ischemic Myocardium (BCVS)
  • 516 - Apoptosis (BCVS)
  • 710 - Experimental Myocardial Infarction (BCVS)
  • 712 - Growth Factors, Cytokines, Signal Transduction (BCVS)
  • 722 - Autonomic, Reflex, and Neurohumoral Control of Circulation (BCVS)
+Melvin L. Marcus Young Investigator Awards in Cardiovascular Sciences
  • 301 - Gene Expression/Molecular Biology (BCVS)
  • 302 - In-Vivo Gene Transfer: Experimental (BCVS)
  • 303 - Cardiac Development (BCVS)
  • 304 - Genetically Engineered Models of Human Disease (BCVS)
  • 401 - Ion Channels and membrane Transporters (BCVS)
  • 402 - Cellular Electrophysiology/Electropharmacology (BCVS)
  • 403 - Arrhythmias in Experimental Models (BCVS)
  • 404 - Cellular Aspects of Excitation-Contraction Coupling (BCVS)
  • 501 - Cardiac Failure and Remodeling (BCVS)
  • 510 - Molecular Basis of Hypertrophy (BCVS)
  • 511 - Cardiac Regeneration/Cellular Therapy - Experimental (BCVS)
  • 512 - Myocardial Structure and Pathology (BCVS)
  • 513 - Ventricular Function/Mechanics(BCVS)
  • 514 - Myocardial Energetics/Intermediary Metabolism (BCVS)
  • 515 - Protection of Ischemic Myocardium (BCVS)
  • 516 - Apoptosis (BCVS)
  • 710 - Experimental Myocardial Infarction (BCVS)
  • 712 - Growth Factors, Cytokines, Signal Transduction (BCVS)
  • 722 - Autonomic, Reflex, and Neurohumoral Control of Circulation (BCVS)
+Laennec Young Clinician Award
  • 101 - Echocardiography: Evaluation of Systolic Function (CLCD)
  • 102 - Echocardiography: Evaluation of Diastolic Function (CLCD)
  • 103 - Echocardiography: Emerging Technologies (CLCD)
  • 104 - Echocardiography in CAD: Stress and Contrast (CLCD)
  • 105 - Echocardiography in Clinical Syndromes: Valve disease, Stroke and Arrhythmias (CLCD)
  • 106 - Nuclear Cardiology: Isotope Imaging and PET (CLCD)
  • 203 - Physiology of Exercise and Pharmacologic Stress (CLCD)
  • 520 - Valvular Heart Disease: Diagnosis, Pathophysiology and Medical Management (CLCD)
  • 405 - ECG and Non-Invasive Arrhythmia Testing/Risk Assessment (CLCD)
  • 406 - Arrhythmias: Diagnosis and Electrophysiology (CLCD)
  • 407 - Treatment of Arrhythmias: Pharmacologic (CLCD)
  • 408 - Treatment of Arrhythmias: Ablation (CLCD)
  • 409 - Treatment of Arrhythmias: ICD/Pacemaker – excluding CRT (CLCD)
  • 504 - Heart Failure: Pathophysiology & Diagnosis (CLCD)
  • 505 - Heart Failure: Pharmacologic Therapy (CLCD)
  • 506 - Heart Failure: Resynchronization Therapy (CLCD)
  • 507 - Heart Failure: Disease Management, Quality of Care, and Clinical Outcomes (CLCD)
  • 508 - Medical Aspects End Stage Heart Failure: Transplantation and Device Therapies (CLCD)
  • 518 - Ventricular Function/Hemodynamics and Biomarkers (CLCD)
  • 519 - Myocardial (including Hypertrophy)/Pericardial Disease (CLCD)
  • 602 - Drug/Catheter Interface (CLCD)
  • 603 - Catheter-Based Coronary Interventions: Stents – Clinical Use (CLCD)
  • 604 - Catheter-Based Coronary Interventions: Experimental & New Technology (CLCD)
  • 606 - Percutaneous Non-Coronary Cardiac Intervention (including Percutaneous Valves) (CLCD)
  • 607 - Catheter-Based Coronary Imaging and Hemodynamics (CLCD)
  • 715 - Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology (CLCD)
  • 716 - Unstable Angina, NSTEMI and STEMI: Prognosis and  Pharmacologic Therapy (CLCD)
  • 721 - Pulmonary Hypertension (CLCD)
+Samuel A. Levine Young Clinical Investigator Award
  • 101 - Echocardiography: Evaluation of Systolic Function (CLCD)
  • 102 - Echocardiography: Evaluation of Diastolic Function (CLCD)
  • 103 - Echocardiography: Emerging Technologies (CLCD)
  • 104 - Echocardiography in CAD: Stress and Contrast (CLCD)
  • 105 - Echocardiography in Clinical Syndromes: Valve disease, Stroke and Arrhythmias (CLCD)
  • 106 - Nuclear Cardiology: Isotope Imaging and PET (CLCD)
  • 203 - Physiology of Exercise and Pharmacologic Stress (CLCD)
  • 520 - Valvular Heart Disease: Diagnosis, Pathophysiology and Medical Management (CLCD)
  • 405 - ECG and Non-Invasive Arrhythmia Testing/Risk Assessment (CLCD)
  • 406 - Arrhythmias: Diagnosis and Electrophysiology (CLCD)
  • 407 - Treatment of Arrhythmias: Pharmacologic (CLCD)
  • 408 - Treatment of Arrhythmias: Ablation (CLCD)
  • 409 - Treatment of Arrhythmias: ICD/Pacemaker – excluding CRT (CLCD)
  • 504 - Heart Failure: Pathophysiology & Diagnosis (CLCD)
  • 505 - Heart Failure: Pharmacologic Therapy (CLCD)
  • 506 - Heart Failure: Resynchronization Therapy (CLCD)
  • 507 - Heart Failure: Disease Management, Quality of Care, and Clinical Outcomes (CLCD)
  • 508 - Medical Aspects End Stage Heart Failure: Transplantation and Device Therapies (CLCD)
  • 518 - Ventricular Function/Hemodynamics and Biomarkers (CLCD)
  • 519 - Myocardial (including Hypertrophy)/Pericardial Disease (CLCD)
  • 602 - Drug/Catheter Interface (CLCD)
  • 603 - Catheter-Based Coronary Interventions: Stents – Clinical Use (CLCD)
  • 604 - Catheter-Based Coronary Interventions: Experimental & New Technology (CLCD)
  • 606 - Percutaneous Non-Coronary Cardiac Intervention (including Percutaneous Valves) (CLCD)
  • 607 - Catheter-Based Coronary Imaging and Hemodynamics (CLCD)
  • 715 - Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology (CLCD)
  • 716 - Unstable Angina, NSTEMI and STEMI: Prognosis and  Pharmacologic Therapy (CLCD)
  • 721 - Pulmonary Hypertension (CLCD)
+Cournand and Comroe Young Investigator Award
  • 410 - Resuscitation, CPR, Emergency Cardiac Care, Critical Care, AED and Trauma (3CPR)
  • 509 - Pulmonary Circulation, Respiratory Processes, and Lung Injury (3CPR)
+Martha N. Hill New Investigator Award
  • 204 - Psychosocial and Behavioral Aspects (CVN)
  • 205 - Prevention, Education, and Disease Management (CVN)
  • 213 - Physiologic Aspects of Acute and Chronic Care (CVN)

+Melvin Judkins Young Clinical Investigator Award
  • 107 - CT Coronary Angiography (CVRI)
  • 108 - CT other (CVRI)
  • 109 - Magnetic Resonance/Clinical Spectroscopy (CVRI)
  • 110 - Non-Coronary Vascular (CVRI)
+Vivien Thomas Young Investigator Award
  • 521 - Cardiac Surgery: Valvular Heart Disease (NOT including Percutaneous Valves) (CVSA)
  • 608 - Thoracic Aortic Disease (CVSA)
  • 502 - Surgical Treatment of Heart Failure, Transplantation, and Arrhythmias (CVSA)
  • 503 - Heart Failure: Cell & Gene Based Therapies (CVSA)
  • 517 - Myocardial Protection/Intraoperative Management (CVSA)
  • 601 - Coronary Artery Disease and Chronic Ischemic Heart Disease (CVSA)
+Elizabeth Barrett-Connor Research Award for Young Investigators in Training
  • 207 - Cardiac Rehabilitation/Exercise (EPI)
  • 208 - Prevention Research: Interventions (Population-Based Interventions, Individual Interventions, Risk Factor Modification Studies, Prevention Trials) (EPI)
  • 211 - Epidemiology: Population Studies, Risk Factors, Biomarkers (EPI)
  • 316 - Genetic Epidemiology (EPI)
+NPAM Young Investigator Award
  • 206 - Clinical and Experimental Aspects of Nutrition (NPAM)
  • 209 - Obesity: Causes and Cardiac Risk (NPAM)
  • 210 - Diabetic CVD: Clinical and Experimental (NPAM)
Travel Stipends
+ATVB Merit Awards for Young Investigators
  • 201 - Lipid and Lipoprotein Metabolism: Basic and Cellular (ATVB)
  • 202 - Lipid and Lipoprotein Metabolism: Clinical (ATVB)
  • 701 - Cell and Developmental Vascular Biology (ATVB)
  • 702 - Mechanisms of Atherosclerosis (ATVB)
  • 703 - Endothelium, Vascular Tone and Nitric Oxide (ATVB)
  • 704 - Proliferation, Remodeling, Extracellular Matrix (ATVB)
  • 705 - Stem/Progenitor Cells (ATVB)
  • 706 - Angiogenesis (ATVB)
  • 707 - Inflammation and Adhesion Molecules (ATVB)
  • 708 - Coronary, Regional and Micro-circulation (ATVB)
  • 709 - Hemostasis, Thrombosis and Fibrinolysis (ATVB)
  • 711 - Oxidant Stress (ATVB)
+BCVS Abstract Travel Grant
  • 301 - Gene Expression/Molecular Biology (BCVS)
  • 302 - In-Vivo Gene Transfer: Experimental (BCVS)
  • 303 - Cardiac Development (BCVS)
  • 304 - Genetically Engineered Models of Human Disease (BCVS)
  • 401 - Ion Channels and membrane Transporters (BCVS)
  • 402 - Cellular Electrophysiology/Electropharmacology (BCVS)
  • 403 - Arrhythmias in Experimental Models (BCVS)
  • 404 - Cellular Aspects of Excitation-Contraction Coupling (BCVS)
  • 501 - Cardiac Failure and Remodeling (BCVS)
  • 510 - Molecular Basis of Hypertrophy (BCVS)
  • 511 - Cardiac Regeneration/Cellular Therapy - Experimental (BCVS)
  • 512 - Myocardial Structure and Pathology (BCVS)
  • 513 - Ventricular Function/Mechanics(BCVS)
  • 514 - Myocardial Energetics/Intermediary Metabolism (BCVS)
  • 515 - Protection of Ischemic Myocardium (BCVS)
  • 516 - Apoptosis (BCVS)
  • 710 - Experimental Myocardial Infarction (BCVS)
  • 712 - Growth Factors, Cytokines, Signal Transduction (BCVS)
  • 722 - Autonomic, Reflex, and Neurohumoral Control of Circulation (BCVS)
+BCVS International Travel Grant
  • 301 - Gene Expression/Molecular Biology (BCVS)
  • 302 - In-Vivo Gene Transfer: Experimental (BCVS)
  • 303 - Cardiac Development (BCVS)
  • 304 - Genetically Engineered Models of Human Disease (BCVS)
  • 401 - Ion Channels and membrane Transporters (BCVS)
  • 402 - Cellular Electrophysiology/Electropharmacology (BCVS)
  • 403 - Arrhythmias in Experimental Models (BCVS)
  • 404 - Cellular Aspects of Excitation-Contraction Coupling (BCVS)
  • 501 - Cardiac Failure and Remodeling (BCVS)
  • 510 - Molecular Basis of Hypertrophy (BCVS)
  • 511 - Cardiac Regeneration/Cellular Therapy - Experimental (BCVS)
  • 512 - Myocardial Structure and Pathology (BCVS)
  • 513 - Ventricular Function/Mechanics(BCVS)
  • 514 - Myocardial Energetics/Intermediary Metabolism (BCVS)
  • 515 - Protection of Ischemic Myocardium (BCVS)
  • 516 - Apoptosis (BCVS)
  • 710 - Experimental Myocardial Infarction (BCVS)
  • 712 - Growth Factors, Cytokines, Signal Transduction (BCVS)
  • 722 - Autonomic, Reflex, and Neurohumoral Control of Circulation (BCVS)

+3CPR Junior Investigator Travel Stipend

  • 410 - Resuscitation, CPR, Emergency Cardiac Care, Critical Care, AED and Trauma (3CPR)
  • 509 - Pulmonary Circulation, Respiratory Processes, and Lung Injury (3CPR)
+CVRI Early Career Investigator Travel Stipend
  • 107 - CT Coronary Angiography (CVRI)
  • 108 - CT other (CVRI)
  • 109 - Magnetic Resonance/Clinical Spectroscopy (CVRI)
  • 110 - Non-Coronary Vascular (CVRI)
+Functional Genomics & Translational Biology Young Investigator Award
  • 305 - Genetics and Genomics of Cardiovascular Disease (FGTB)
  • 306 - Human Genetics and Genomics of Cardiovascular Disease and Therapy (FGTB)